You need money, lots of it to do clinical trials. NVGN will surely issue a huge amount of shares and raise money after this surge today. SELL, SELL, SELL...or **lose 50%**, easily.
How will it fail? Entirely....as a company. SELL!!!
Because today's results tell you it's a long road ahead for OXGN which means more capital raises coming and move crashes downwards...SELL!
The results were NOT good enough when you look at only a **couple** of months more of survival. Not good enough! We need either a cure or "years" of extra survival in cancer....not "2" or so months like OXGN just showed. NOT good enough.
Companies say it's positive if the survival increased by "just a few months"...but as an investment or as a regulatory approval it's NOT good enough. Failure!!!
NOT worth the investment or the long term hold. OXGN will do what ONCY recently did...crash at least 50% when it's results were spun as "positive" by the company, but the market sees as being "NOT GOOD ENOUGH" folks. SELL immediately at the open!!!
SELL....AEZS going to $0.25
It needs to retest the lows in the $1.85 to $2.00 area before finally surging for good.
VPCO is facing way too much competition and in some place regulations. SELL. AVOID buying into the day trading hype.
ASTI always issues these flakey long term vision news releases...but in the meantime are losing tons of money and will never get to be profitable. Inevitable bankruptcy. SELL!
Nasdaq doesn't tolerate companies that investors cannot trust. Nasdaq will boot CBDE down to the pink sheets probably within a week. That will cause the next crash to 50 cents.
SELL!!! It's a very weak stock. Clear sign of what's to come.